Moxifloxacin Micro Labs

Moxifloxacin, the active ingredient in Moxifloxacin Micro Labs, is a fluoroquinolone presented as an oral dosage form for oral use. It treats a range of bacterial infections, particularly in adult patients with community‑acquired pneumonia, sinusitis, bronchitis exacerbations, and skin‑structure infections.

GNH USA supplies Moxifloxacin Micro Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable sourcing for global healthcare providers.

Moxifloxacin is a fluoroquinolone antibacterial indicated for several bacterial infections affecting the respiratory tract and skin.

- Community‑acquired bacterial pneumonia: effective in treating infection caused by susceptible organisms. - Acute bacterial sinusitis: clears sinus infection when caused by susceptible bacteria. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves symptoms. - Skin and skin‑structure infections: combats susceptible Gram‑positive and Gram‑negative pathogens.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: can lead to cardiac arrhythmias. - Severe allergic reactions: including anaphylaxis, skin rash, or angioedema.

When prescribing Moxifloxacin, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: adjust therapy if impairment is present. - Avoid use in patients with known tendon disorders: increased risk of tendon injury. - Monitor QT interval: especially when combined with other QT‑prolonging agents. - Use with caution in elderly patients: higher incidence of adverse events. - Store at room temperature: keep in the original container, protect from moisture and light.

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: heightened risk of tendon rupture. - Co‑administration with other fluoroquinolones: additive toxicity. - Combination with QT‑prolonging drugs: may cause serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: reduce oral absorption of moxifloxacin. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: possible increase in serum theophylline concentrations.